Synthekine
Cytokines by Design
Menlo Park, United States · $289.5M raised
- Headquarters
- Menlo Park, California
- Business Model
- B2B
- Website
- synthekine.com
- Total Funding
- $289.5M
- Last Round
- $100.0M Series CSep 2023
- Rounds
- 3
About
Biotechnology company engineering novel cytokines to advance immunology and develop next-generation therapeutics.
Summary
Synthekine is a Biotech company based in Menlo Park, United States. It has raised $289.5M in total across 3 rounds, most recently a $100.0M Series C round in Sep 2023. Investors include The Column Group, Deerfield Management and Janus Henderson Investors.
Tech & App Stack
5 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sep 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...